The invention provides 3-arylethynyl substituted quinazolinone compounds of formula A as potential anticancer agents against sixty human cancer cell lines.
Filing Date:
15-02-2011
Issue Date:
16-08-2018
Applicant:
CSIR-Indian Institute of Chemical Technology (CSIR-IICT), Hyderabad
Acces sibility Controls